Too early and widespread expression of PAX3-FOXO1 expression can result in developmental defects and no apparent tumor development [120-123], whereas later expression of PAX3-FOXO1, via a Myf6-driven Cre recombinase, does cause disease, though at a low frequency [47]. Here, FOXO1 is linked to neoplasm.